← Back to Search

Other

Dietary Supplements + Exercise for Weight Loss

Phase 3
Recruiting
Led By Michaela Devries-Aboud, PhD
Research Sponsored by Exerkine Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have had two doses of the COVID-19 vaccine
Age 18 - 45 years
Must not have
Cardiovascular disease (recent myocardial infarction (< 6 months), hypertension requiring more than 2 medications, congestive heart failure requiring more than one medication for control, unstable arrhythmia, angina previous stroke with residual hemiparesis)
Individuals with prior bariatric surgery
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline 0 weeks ("pre study"), 6 weeks ("midway"), and 12 weeks ("post study")
Awards & highlights
Pivotal Trial

Summary

This trial tests whether taking two dietary supplements along with regular exercise can help overweight and obese people lose weight and improve their health more effectively than just exercising alone.

Who is the study for?
This trial is for men and women aged 18-45 with a BMI over 25 who are not very active, have had two COVID-19 vaccine doses, and don't have certain health conditions like severe osteoporosis or uncontrolled hypertension. It's not for those with GI disorders, muscular dystrophy, liver disease, cardiovascular issues, diabetes, orthopedic problems, respiratory conditions or those on specific medications.
What is being tested?
The TRIM MUSCLE Study tests if the supplements Muscle5 (protein mix) and TRIM7 (antioxidants & stimulants), combined with mixed exercise (aerobic and resistance training), lead to better weight loss quality than exercise alone in overweight individuals. The study also looks at how these affect inflammation levels, insulin sensitivity, stress perception and overall health.
What are the potential side effects?
Potential side effects from the supplements may include digestive discomfort due to beet extract or caffeine-related symptoms such as jitteriness or increased heart rate. Exercise can cause muscle soreness or fatigue. Individual reactions to the supplement ingredients will vary.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have received two doses of the COVID-19 vaccine.
Select...
I am between 18 and 45 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have serious heart or stroke issues needing multiple medications.
Select...
I have had weight loss surgery in the past.
Select...
I have a gastrointestinal disorder like Colitis or Crohn's.
Select...
I have severe nerve pain or numbness in my hands or feet.
Select...
I have type I or II diabetes.
Select...
I have muscular dystrophy.
Select...
I have severe osteoporosis.
Select...
I have been diagnosed with a liver condition.
Select...
I have a history of glaucoma or overactive bladder.
Select...
My blood pressure is not higher than 140/90 mmHg.
Select...
I have severe joint pain due to osteoarthritis.
Select...
I have lost 10% of my body weight in the last 3 months.
Select...
I have a lung condition needing more than two medications.
Select...
My kidney function is normal.
Select...
I consume less than 10 drinks a week if female, or 15 if male.
Select...
I am unable to give consent by myself.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline 0 weeks ("pre study"), 6 weeks ("midway"), and 12 weeks ("post study")
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline 0 weeks ("pre study"), 6 weeks ("midway"), and 12 weeks ("post study") for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
BMI change
Bodyweight change
Fat mass change
+4 more
Secondary study objectives
Antioxidant capacity change
Appendicular lean mass change
Lipids
+9 more
Other study objectives
Female hair growth & quality (WHGQ)
Health-related quality of life (SF 36)
Male hair growth & quality (Merk & Co, 1996)
+4 more

Awards & Highlights

Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Muscle5 and TRIM7Active Control2 Interventions
MUSCLE5 and TRIM7 natural health product supplementation Name of natural health product (brand name, generic) - MUSCLE 5, chocolate Is this a market-approved natural health product (per Health Canada)? - Yes Dose - 1 scoop Ingredients (per dose) - Whey protein isolate (24g), milk protein isolate (16g), Creatine (3g), Calcium (450mg), Vitamin D (1000 IU) Frequency of administration - Once/day Duration (e.g., six weeks) - 12 weeks Route of administration - Oral Name of natural health product (brand name, generic) - TRIM7 Is this a market-approved natural health product (as per Health Canada)? Yes Dose - 3 capsules Ingredients (per dose) - Alpha lipoic acid (200mg), CoEnzyme Q10 (100mg), beet root extract (250mg), green coffee bean extract (250mg), green tea extract (250mg), forskolin (25mg), Vitamin E (22 mg AT) Frequency of administration - Twice/day Duration (e.g., six weeks) - 12 weeks Route of administration - Oral
Group II: PlaceboPlacebo Group1 Intervention
Placebo collagen and microcrystalline cellulose intake Placebo Control 1 (Counter to MUSCLE5) Dose - 1 scoop Ingredients (per dose) - Collagen (40g) Frequency of administration - once/day Duration - 12 weeks Route of administration - Oral Placebo Control 2 (Counter to TRIM7) Dose - 3 capsules Ingredients (per dose) - Microcrystalline cellulose (400 mg) Frequency of administration - twice/day Duration - 12 weeks Route of administration - Oral

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for obesity, such as those studied in the MUSCLE 5 and TRIM 7 supplements, work through various mechanisms to enhance muscle building, fat loss, and overall health. Protein supports muscle growth and repair, which can increase metabolic rate and aid in fat loss. Creatine enhances muscle strength and performance, allowing for more effective workouts. Vitamins like D and E play roles in metabolic processes and antioxidant protection, improving overall health. Extracts such as green tea and green coffee bean boost metabolism and fat oxidation, while compounds like forskolin and coenzyme Q10 support energy production and reduce inflammation. These mechanisms are crucial for obesity patients as they not only promote weight loss but also improve muscle mass, metabolic health, and reduce the risk of obesity-related complications.
Magnetic fields modulate metabolism and gut microbiome in correlation with Pgc-1α expression: Follow-up to an in vitro magnetic mitohormetic study.Insulin resistance and sarcopenia: mechanistic links between common co-morbidities.Febuxostat improves outcome in a rat model of cancer cachexia.

Find a Location

Who is running the clinical trial?

Exerkine CorporationLead Sponsor
University of WaterlooOTHER
127 Previous Clinical Trials
214,772 Total Patients Enrolled
3 Trials studying Obesity
1,602 Patients Enrolled for Obesity
Michaela Devries-Aboud, PhDPrincipal InvestigatorKinesiology and Health Sciences, University of Waterloo

Media Library

Mixed exercise (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05384431 — Phase 3
Obesity Research Study Groups: Placebo, Muscle5 and TRIM7
Obesity Clinical Trial 2023: Mixed exercise Highlights & Side Effects. Trial Name: NCT05384431 — Phase 3
Mixed exercise (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05384431 — Phase 3
~19 spots leftby Nov 2025